177 related articles for article (PubMed ID: 25690668)
1. von Willebrand factor arginine 1205 substitution results in accelerated macrophage-dependent clearance in vivo.
Rawley O; O'Sullivan JM; Chion A; Keyes S; Lavin M; van Rooijen N; Brophy TM; Fallon P; Preston RJ; O'Donnell JS
J Thromb Haemost; 2015 May; 13(5):821-6. PubMed ID: 25690668
[TBL] [Abstract][Full Text] [Related]
2. N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor.
O'Sullivan JM; Aguila S; McRae E; Ward SE; Rawley O; Fallon PG; Brophy TM; Preston RJ; Brady L; Sheils O; Chion A; O'Donnell JS
J Thromb Haemost; 2016 Dec; 14(12):2446-2457. PubMed ID: 27732771
[TBL] [Abstract][Full Text] [Related]
3. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
4. N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance.
Chion A; O'Sullivan JM; Drakeford C; Bergsson G; Dalton N; Aguila S; Ward S; Fallon PG; Brophy TM; Preston RJ; Brady L; Sheils O; Laffan M; McKinnon TA; O'Donnell JS
Blood; 2016 Oct; 128(15):1959-1968. PubMed ID: 27554083
[TBL] [Abstract][Full Text] [Related]
5. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
[TBL] [Abstract][Full Text] [Related]
6. Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza.
Gézsi A; Budde U; Deák I; Nagy E; Mohl A; Schlammadinger A; Boda Z; Masszi T; Sadler JE; Bodó I
J Thromb Haemost; 2010 Jun; 8(6):1273-80. PubMed ID: 20088930
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
8. An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation.
Lenting PJ; Westein E; Terraube V; Ribba AS; Huizinga EG; Meyer D; de Groot PG; Denis CV
J Biol Chem; 2004 Mar; 279(13):12102-9. PubMed ID: 14613933
[TBL] [Abstract][Full Text] [Related]
9. Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance.
Castaman G; Tosetto A; Rodeghiero F
J Thromb Haemost; 2009 Jul; 7 Suppl 1():71-4. PubMed ID: 19630772
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of enhanced von Willebrand factor clearance from plasma.
Seidizadeh O; Baronciani L; Pagliari MT; Cozzi G; Colpani P; Cairo A; Siboni SM; Biguzzi E; Peyvandi F
J Thromb Haemost; 2023 May; 21(5):1112-1122. PubMed ID: 36754679
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the Misfolding of the A1 Domain within Multimeric von Willebrand Factor in Type 2 von Willebrand Disease.
Tischer A; Brehm MA; Machha VR; Moon-Tasson L; Benson LM; Nelton KJ; Leger RR; Obser T; Martinez-Vargas M; Whitten ST; Chen D; Pruthi RK; Bergen HR; Cruz MA; Schneppenheim R; Auton M
J Mol Biol; 2020 Jan; 432(2):305-323. PubMed ID: 31628947
[TBL] [Abstract][Full Text] [Related]
12. Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance.
Wohner N; Legendre P; Casari C; Christophe OD; Lenting PJ; Denis CV
J Thromb Haemost; 2015 May; 13(5):815-20. PubMed ID: 25728415
[TBL] [Abstract][Full Text] [Related]
13. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
Castaman G; Tosetto A; Federici AB; Rodeghiero F
Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
[TBL] [Abstract][Full Text] [Related]
14. Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival.
Casonato A; Galletta E; Galvanin F; Daidone V
EJHaem; 2021 Aug; 2(3):340-348. PubMed ID: 35844701
[TBL] [Abstract][Full Text] [Related]
15. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.
Eikenboom JC; Matsushita T; Reitsma PH; Tuley EA; Castaman G; Briët E; Sadler JE
Blood; 1996 Oct; 88(7):2433-41. PubMed ID: 8839833
[TBL] [Abstract][Full Text] [Related]
16. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.
Millar CM; Riddell AF; Brown SA; Starke R; Mackie I; Bowen DJ; Jenkins PV; van Mourik JA
Thromb Haemost; 2008 May; 99(5):916-24. PubMed ID: 18449422
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory phenotype variability in type 2M von Willebrand disease.
Doruelo AL; Haberichter SL; Christopherson PA; Boggio LN; Gupta S; Lentz SR; Shapiro AD; Montgomery RR; Flood VH
J Thromb Haemost; 2017 Aug; 15(8):1559-1566. PubMed ID: 28544236
[TBL] [Abstract][Full Text] [Related]
18. Reduced von Willebrand factor survival in type Vicenza von Willebrand disease.
Casonato A; Pontara E; Sartorello F; Cattini MG; Sartori MT; Padrini R; Girolami A
Blood; 2002 Jan; 99(1):180-4. PubMed ID: 11756169
[TBL] [Abstract][Full Text] [Related]
19. von Willebrand factor clearance - biological mechanisms and clinical significance.
O'Sullivan JM; Ward S; Lavin M; O'Donnell JS
Br J Haematol; 2018 Oct; 183(2):185-195. PubMed ID: 30378120
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome.
Stufano F; Boscarino M; Bucciarelli P; Baronciani L; Maino A; Cozzi G; Peyvandi F
Semin Thromb Hemost; 2019 Feb; 45(1):36-42. PubMed ID: 29913537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
